Skip to main content
Clinical Trials/NCT03561987
NCT03561987
Unknown
Not Applicable

Identification of Biomarkers Derived From Adipose Tissue With Potential Utility in the Diagnosis and Prognosis of Cardiovascular Risk of the Obese Patient.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Enrollment
70
Primary Endpoint
Evaluate the association of the cardiovascular benefit of the obese patient after bariatric surgery with the basic mechanisms of adipose tissue (metabolic profile)
Last Updated
7 years ago

Overview

Brief Summary

This study evaluates the relationship between the adipose tissue, as an active component, which can define metabolic phenotypes linked to cardiovascular risk modification post bariatric surgery.

Detailed Description

Bariatric surgery induces a significant reduction in co-morbidities associated with obesity, such as Diabetes mellitus, dyslipidemia, liver disease, arterial hypertension, obstructive apnea and cardiovascular risk. However this does not happen in all obese patients, even when there is a weight reduction. It is known that the adipose tissue is actively involved in synthesis of cytokines and its role in metabolic phenotypes has been suggested. It is possible that the intrinsic mechanisms of adipose tissue participate in several benefits observed in morbidly obese patients who undergo to an anti-obesity surgery. So this study explores the involvement of adipose tissue as an active component, which can define metabolic phenotypes linked to cardiovascular risk modification post bariatric surgery.

Registry
clinicaltrials.gov
Start Date
November 6, 2013
End Date
January 15, 2022
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Juan Antonio Suárez Cuenca

Ph.D. in Biomedical sciences

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Eligibility Criteria

Inclusion Criteria

  • Above 18 years old.
  • Morbid obese patients candidates to bariatric surgery.

Exclusion Criteria

  • Second bariatric surgery

Outcomes

Primary Outcomes

Evaluate the association of the cardiovascular benefit of the obese patient after bariatric surgery with the basic mechanisms of adipose tissue (metabolic profile)

Time Frame: 3 years

Evaluate the association of the cardiovascular benefit of the obese patient after bariatric surgery with the basic mechanisms of adipose tissue (metabolic profile)

Secondary Outcomes

  • Correlation between serum concentration of pro-inflammatory biomarker and the reduction of subclinical endothelial disfunction.(9 months)
  • Determine the association of the cardiovascular prognosis modification (risk subgroups) with the basal metabolic profile.(9 months)

Similar Trials